The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.
Oncologist migration patterns in the US may drive geographical care disparities, according to a poster presented at ASCO 2026.
The study assessed the safety and outcomes of pemivibart in the oncology subset from the open-label, single-arm, immunocompromised Cohort A of the phase 3 CANOPY trial. The oncology subset included 55 Cohort A participants (18.0% of 306 Cohort A participants).
First-line treatment with golcadomide, a first-in-class oral cereblon E3 ligase modulator, plus Pola-RCHP resulted in predictable and manageable safety outcomes without compromising Pola-RCHP dose intensity for patients with aggressive B-cell lymphoma in the ongoing GOLSEEK-1 trial.
The US Food and Drug Administration has granted Orphan Drug Designation to EO2463 immunotherapy for the treatment of patients with indolent non-Hodgkin lymphoma (iNHL) in
The drug had earlier received the FDA’s breakthrough designation and orphan drug designation, making the application eligible for priority review. Efficacy was evaluated in CADENZA, a multicenter, open-label, single-arm clinical trial that included adult patients with treatment-naïve BPDCN (N=33) or relapsed or refractory BPDCN (N=51), without evidence of active central nervous system disease.
Anthony Stein, MD, of the Gehr Family Center for Leukemia Research at City of Hope in California, and colleagues, conducted the single-center, open-label, phase II study that included patients aged 16 to 60 years with acute myeloid leukemia or acute lymphoblastic leukemia.
SOHO Insider is the official media platform of the Society of Hematologic Oncology. The SOHO Insider Editorial Board is comprised of leading hematologists. Learn more about our editorial board and SOHO Insider platforms.
To access the SOHO Career Center click the following link.
